insights_auto
Why is ATOS up 8.47%?
Dive Deeperchevron_right
ATOS:NASDAQ
Atossa Therapeutics Inc
$2.62
arrow_upward
+8.47%(+0.20) 1D
Oct 9, 2:51:22 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ATOS...
Open
$2.45
High
$2.74
Low
$2.12
Mkt. cap
26.20M
Avg. vol.
59.58K
Volume
188.76K
52-wk high
$19.35
52-wk low
$1.70
EPS
-$4.34
Beta
1.27
Shares outstanding
9.98M
No. of employees
16
Open
$2.45
High
$2.74
Low
$2.12
Mkt. cap
26.20M
Avg. vol.
59.58K
Volume
188.76K
52-wk high
$19.35
52-wk low
$1.70
EPS
-$4.34
Beta
1.27
Shares outstanding
9.98M
No. of employees
16
News stories
From web sources and news partners
TipRanks
·
2 hours ago
Atossa’s (Z)-Endoxifen Trial Targets Rare Childhood Puberty Disorder, Opening a New Pipeline Angle
TipRanks
·
6 hours ago
Atossa Therapeutics Announces CVR Dividend for Shareholders
Investing.com
·
6 hours ago
Atossa Therapeutics executes CVR agreement for voucher proceeds
About Atossa Therapeutics Inc
CEOSteven C. Quay
Employees16
Founded2008
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteatossatherapeutics.com